Patents by Inventor Joseph FARTHING

Joseph FARTHING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cisplatin particles and uses thereof
    Publication number: 20250360166
    Abstract: Compositions of particles having at least 95% by weight of cisplatin and a specific surface area (SSA) of at least 3.5 m2/g. methods for their use. and methods for their production are provided.
    Type: Application
    Filed: August 7, 2025
    Publication date: November 27, 2025
    Inventors: Jacob SITTENAUER, Aranza Barreda ABARCA, Joseph FARTHING, Mark WILLIAMS, Michael BALTEZOR
  • Taxane Particles and Their Use
    Publication number: 20250186390
    Abstract: Compositions are provided that include having at least 95% by weight of a taxane, or a pharmaceutically acceptable salt thereof, where the particles have a mean bulk density between about 0.050 g/cm3 and about 0.15 g/cm3, and/or a specific surface area (SSA) of at least 18 m2/g, 20 m2m/g, 25 m2/g, 30 m2/g, 32 m2/g, 34 m2/g, or 35 m2/g. Methods for making and using such compositions are also provided.
    Type: Application
    Filed: October 31, 2024
    Publication date: June 12, 2025
    Inventors: Michael BALTEZOR, Joseph FARTHING, Jake SITTENAUER, Jahna ESPINOSA, Samuel CAMPBELL, Matthew MCCLOREY, Julia K. FISCHER, Mark D. WILLIAMS, Gary E. CLAPP
  • Lapatinib particles and uses thereof
    Patent number: 12029818
    Abstract: The disclosure provides particles of at least 95% by weight of lapatinib, or a pharmaceutically acceptable salt thereof, wherein the particles have a specific surface area (SSA) of at least 10 m2/g and have a mean particle size by volume distribution of between about 0.7 ?m and about 8 ?m.
    Type: Grant
    Filed: July 14, 2022
    Date of Patent: July 9, 2024
    Assignee: CRITITECH, INC.
    Inventors: Jacob Sittenauer, Joseph Farthing, Mark Williams, Michael Baltezor, Gere Dizerega, Aranza Barreda Abarca, Shelby Clark
  • CISPLATIN PARTICLES AND USES THEREOF
    Publication number: 20240216424
    Abstract: Compositions of particles having at least 95% by weight of cisplatin and a specific surface area (8SA) of at least 3.5 m2/g. methods for their use. and methods for their production are provided.
    Type: Application
    Filed: April 25, 2022
    Publication date: July 4, 2024
    Inventors: Jacob SITTENAUER, Aranza Barreda ABARCA, Joseph FARTHING, Mark WILLIAMS, Michael BALTEZOR
  • Cisplatin particles and uses thereof
    Publication number: 20240156861
    Abstract: Suspensions and their use for treating tumors are provided, where the suspensions include (a) particles of at least 95% by weight of cisplatin, wherein the particles have a specific surface area (SSA) of at least 3.5 m2/g, (b) about 40% to about 60% w/w of glycerin, (c) about 20% to about 40% w/w of propylene glycol, (d) about 5% to about 20% w/w of ethanol, and (e) about 5% to about 10% w/w of 0.9% sodium chloride in water.
    Type: Application
    Filed: October 23, 2023
    Publication date: May 16, 2024
    Inventors: Michael Baltezor, Holly Maulhardt, Maria Montes-Gonzalez, Jahna Espinosa, Mark Williams, Joseph Farthing, Jacob Sittenauer
  • NICLOSAMIDE PARTICLES AND USES THEREOF
    Publication number: 20230414510
    Abstract: The disclosure provides compositions and methods for use of compositions that include particles comprising at least 30% niclosamide by weight, or a pharmaceutically acceptable salt, hydrate, or solvate thereof, wherein the particles have one or more of: (i) a mean bulk density (not tapped) of less than 0.40 g/cm3; 00 a mean tapped density of less than 0.55 g/cm 3 ; and/or (in) a specific surface area (SSA) of at least 3.6 m2/g.
    Type: Application
    Filed: September 8, 2021
    Publication date: December 28, 2023
    Inventors: Michael BALTEZOR, Jacob SITTENAUER, Joseph FARTHING, Mark WILLIAMS, Aranza Barreda ABARCA
  • Sorafenib particles and uses thereof
    Publication number: 20230364021
    Abstract: Particles of at least 95% by weight of sorafenib, or a pharmaceutically acceptable salt thereof are provided, wherein the particles have a specific surface area (SSA) of at least 2 m2/g and have a mean particle size by volume distribution of between about 0.7 ?m and about 8 ?m, as are methods for their use, and methods for making such particles.
    Type: Application
    Filed: July 18, 2023
    Publication date: November 16, 2023
    Inventors: Jacob SITTENAUER, Joseph FARTHING, Mark WILLIAMS, Michael BALTEZOR, Gere DIZEREGA, Aranza Barreda ABARCA, Shelby CLARK
  • Niraparib particles and uses thereof
    Patent number: 11738014
    Abstract: Compositions of particles having at least 95% by weight of niraparib and a specific surface area (SSA) of at least 5 m2/g, methods for their use, and methods for their production are provided.
    Type: Grant
    Filed: November 8, 2022
    Date of Patent: August 29, 2023
    Assignee: Crititech, Inc.
    Inventors: Jacob Sittenauer, Aranza Barreda Abarca, Shelby Clark, Joseph Farthing, Mark Williams, Gere Dizerega, Michael Baltezor
  • Rucaparib particles and uses thereof
    Patent number: 11738029
    Abstract: Compositions of particles having at least 95% by weight of rucaparib and a specific surface area (SSA) of at least 12 m2/g, methods for their use, and methods for their production are provided.
    Type: Grant
    Filed: November 8, 2022
    Date of Patent: August 29, 2023
    Assignee: CRITITECH, INC.
    Inventors: Jacob Sittenauer, Aranza Barreda Abarca, Shelby Clark, Joseph Farthing, Mark Williams, Gere Dizerega, Michael Baltezor
  • Niraparib particles and uses thereof
    Publication number: 20230142591
    Abstract: Compositions of particles having at least 95% by weight of niraparib and a specific surface area (SSA) of at least 5 m2/g, methods for their use, and methods for their production are provided.
    Type: Application
    Filed: November 8, 2022
    Publication date: May 11, 2023
    Inventors: Jacob SITTENAUER, Aranza Barreda ABARCA, Shelby CLARK, Joseph FARTHING, Mark WILLIAMS, Gere DIZEREGA, Michael BALTEZOR
  • Rucaparib particles and uses thereof
    Publication number: 20230142186
    Abstract: Compositions of particles having at least 95% by weight of rucaparib and a specific surface area (SSA) of at least 12 m2/g, methods for their use, and methods for their production are provided.
    Type: Application
    Filed: November 8, 2022
    Publication date: May 11, 2023
    Inventors: Jacob SITTENAUER, Aranza Barreda ABARCA, Shelby CLARK, Joseph FARTHING, Mark WILLIAMS, Gere DIZEREGA, Michael BALTEZOR
  • Lapatinib particles and uses thereof
    Publication number: 20220370355
    Abstract: The disclosure provides particles of at least 95% by weight of lapatinib, or a pharmaceutically acceptable salt thereof, wherein the particles have a specific surface area (SSA) of at least 10 m2/g and have a mean particle size by volume distribution of between about 0.7 ?m and about 8 ?m.
    Type: Application
    Filed: July 14, 2022
    Publication date: November 24, 2022
    Inventors: Jacob SITTENAUER, Joseph FARTHING, Mark WILLIAMS, Michael BALTEZOR, Gere DIZEREGA, Aranza Barreda ABARCA, Shelby CLARK
  • Sorafenib particles and uses thereof
    Publication number: 20220241257
    Abstract: The disclosure provides particles of at least 95% by weight of sorafenib, or a pharmaceutically acceptable salt thereof, wherein the particles have a specific surface area (SSA) of at least 2 m2/g and have a mean particle size by volume distribution of between about 0.7 ?m and about 8 ?m, methods for their use, and methods for making such particles.
    Type: Application
    Filed: July 21, 2021
    Publication date: August 4, 2022
    Inventors: Jacob SITTENAUER, Joseph FARTHING, Mark WILLIAMS, Michael BALTEZOR, Gere DIZEREGA, Aranza Barreda ABARCA, Shelby CLARK
  • Lapatinib particles and uses thereof
    Publication number: 20220023215
    Abstract: The disclosure provides particles of at least 95% by weight of lapatinib, or a pharmaceutically acceptable salt thereof, wherein the particles have a specific surface area (SSA) of at least 10 m2/g and have a mean particle size by volume distribution of between about 0.7 ?m and about 8 ?m.
    Type: Application
    Filed: July 21, 2021
    Publication date: January 27, 2022
    Inventors: Jacob SITTENAUER, Joseph FARTHING, Mark WILLIAMS, Michael BALTEZOR, Gere DIZEREGA, Aranza Barreda ABARCA, Shelby CLARK
  • Taxane Particles and Their Use
    Publication number: 20210393569
    Abstract: Compositions are provided that include having at least 95% by weight of a taxane, or a pharmaceutically acceptable salt thereof, where the particles have a mean bulk density between about 0.050 g/cm3 and about 0.15 g/cm3, and/or a specific surface area (SSA) of at least 18 m2/g, 20 m2/g, 25 m2/g, 30 m2/g, 32 m2/g, 34 m2/g, or 35 m2/g. Methods for making and using such compositions are also provided.
    Type: Application
    Filed: September 7, 2021
    Publication date: December 23, 2021
    Inventors: Michael BALTEZOR, Joseph FARTHING, Jake SITTENAUER, Jahna ESPINOSA, Samuel CAMPBELL, Matthew MCCLOREY, Julia K. FISCHER, Mark D. WILLIAMS, Gary E. CLAPP
  • CIPROFLOXACIN POLYMORPH AND ITS USE
    Publication number: 20210387961
    Abstract: The present disclosure relates to ciprofloxacin polymorphs and their use in treating infections.
    Type: Application
    Filed: August 13, 2021
    Publication date: December 16, 2021
    Inventors: Mark WILLIAMS, Jacob SITTENAUER, Shelby CLARK, Joseph FARTHING, Michael BALTEZOR, Matthew MCCLOREY
  • Taxane particles and their use
    Patent number: 11123322
    Abstract: Compositions are provided that include having at least 95% by weight of a taxane, or a pharmaceutically acceptable salt thereof, where the particles have a mean bulk density between about 0.050 g/cm3 and about 0.15 g/cm3, and/or a specific surface area (SSA) of at least 18 m2/g, 20 m2/g, 25 m2/g, 30 m2/g, 32 m2/g, 34 m2/g, or 35 m2/g. Methods for making and using such compositions are also provided.
    Type: Grant
    Filed: October 30, 2019
    Date of Patent: September 21, 2021
    Assignee: Crititech, Inc.
    Inventors: Michael Baltezor, Joseph Farthing, Jake Sittenauer, Jahna Espinosa, Samuel Campbell, Matthew McClorey, Julia K. Fischer, Mark D. Williams, Gary E. Clapp
  • Ciprofloxacin polymorph and its use
    Patent number: 11104663
    Abstract: The present disclosure relates to ciprofloxacin polymorphs and their use in treating infections.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: August 31, 2021
    Assignee: CritiTech, Inc.
    Inventors: Mark Williams, Jacob Sittenauer, Shelby Clark, Joseph Farthing, Michael Baltezor, Matthew McClorey
  • Taxane particles and their use
    Patent number: 10993927
    Abstract: Compositions are provided that include having at least 95% by weight of a taxane, or a pharmaceutically acceptable salt thereof, where the particles have a mean bulk density between about 0.050 g/cm3 and about 0.15 g/cm3, and/or a specific surface area (SSA) of at least 18 m2/g, 20 m2/g, 25 m2/g, 30 m2/g, 32 m2/g, 34 m2/g, or 35 m2/g. Methods for making and using such compositions are also provided.
    Type: Grant
    Filed: September 17, 2020
    Date of Patent: May 4, 2021
    Assignee: Crititech, Inc.
    Inventors: Michael Baltezor, Joseph Farthing, Jake Sittenauer, Jahna Espinosa, Samuel Campbell, Matthew McClorey, Julia K. Fischer, Mark D. Williams, Gary E. Clapp
  • Taxane Particles and Their Use
    Publication number: 20210000786
    Abstract: Compositions are provided that include having at least 95% by weight of a taxane, or a pharmaceutically acceptable salt thereof, where the particles have a mean bulk density between about 0.050 g/cm3 and about 0.15 g/cm3, and/or a specific surface area (SSA) of at least 18 m2/g, 20 m2/g, 25 m2/g, 30 m2/g, 32 m2/g, 34 m2/g, or 35 m2/g. Methods for making and using such compositions are also provided.
    Type: Application
    Filed: September 17, 2020
    Publication date: January 7, 2021
    Inventors: Michael BALTEZOR, Joseph FARTHING, Jake SITTENAUER, Jahna ESPINOSA, Samuel CAMPBELL, Matthew MCCLOREY, Julia K. FISCHER, Mark D. WILLIAMS, Gary E. CLAPP